Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from ADMA Biologics ( (ADMA) ) is now available.
Bryant E. Fong has resigned from ADMA Biologics’ Board of Directors to focus on his roles at Biomark Capital Fund and Stonepine Capital Management, with no disagreements reported. Young T. Kwon, PhD steps in as Chairman of the Audit Committee, alongside new committee members Steven A. Elms and Alison C. Finger, signaling a strategic reshuffle in the company’s governance.
Find detailed analytics on ADMA stock on TipRanks’ Stock Analysis page.
